Ragok Medicare Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 13-12-2024
- Paid Up Capital ₹ 0.10 M
as on 13-12-2024
- Company Age 6 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2020)
- Profit -253.90%
(FY 2020)
- Ebitda -116.23%
(FY 2020)
- Net Worth -46.54%
(FY 2020)
- Total Assets 1637.04%
(FY 2020)
About Ragok Medicare
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Dhanesh Mehta, Parul Kikani, and Neil Kikani serve as directors at the Company.
- CIN/LLPIN
U51909TZ2018PTC030722
- Company No.
030722
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Jul 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Coimbatore
Industry
Company Details
- Location
Coimbatore, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media
What products or services does Ragok Medicare Private Limited offer?
Ragok Medicare Private Limited offers a wide range of products and services, including Healthcare Products & Aids, Steam Vaporizer, Medical Laboratory Instruments, Rapid Test Kit, Testing & Measuring Equipments, Test Kits, Bandages & Dressing Disposables, Medical Tapes, Plastic & Glass Labware, Laboratory Plasticware.
Who are the key members and board of directors at Ragok Medicare?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Neil Kikani  | Director | 13-Jul-2018 | Current |
| Dhanesh Mehta | Director | 14-Dec-2018 | Current |
| Parul Kikani | Director | 13-Jul-2018 | Current |
Financial Performance of Ragok Medicare.
Ragok Medicare Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 253.9% decrease in profit. The company's net worth observed a substantial decline by a decrease of 46.54%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ragok Medicare?
Unlock access to Ragok Medicare's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ragok Medicare?
Unlock and access historical data on people associated with Ragok Medicare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ragok Medicare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ragok Medicare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
